The expression of ADAMTS8 has been negatively correlated with tumor progression in several experimental models, including brain tumors, breast carcinoma, non–small cell lung carcinoma, head and neck squamous cell carcinoma, and pancreatic cancer, while in some other solid cancers, its role still remains unclear [11]. Here, ADAMTS8 is linked to neoplasm.